News › Industry News, State Laws

Miami-Dade Med Spa Owner Accused of Illegally Selling Ozempic Equivalent, Other Weight Loss Meds

March 20, 2025

Following an undercover investigation, Miami-Dade deputies arrested a medical spa owner who they say sold products with the active ingredients of prescription weight loss medication. She is a licensed massage therapist and not licensed to prescribe drugs, according to the Florida Department of Health.

The sheriff’s office had received complaints of the woman “selling and distributing lollipops containing phentermine” (controlled substance used for weight loss), along with semaglutide (active ingredient in Ozempic and Wegovy) and tirzepatide (active ingredient in Mounjaro and Zepbound), according to the arrest report.

Undercover investigators visited her business on Sept. 27 and purchased three lollipops over the counter. An investigator returned last Wednesday to purchase 10 more lollipops. On Tuesday, deputies executed a search warrant, leading to the woman’s arrest.

The woman faces charges of practicing medicine without a license, dispensing drugs without a license and possession of a controlled substance.

Read more at WPLG Local 10 >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Allergan Aesthetics’ Skinvive by Juvéderm Receives FDA Approval for the Improvement of Neck Appearance
    • Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid Gel
    • MedSafe Becomes Gold Vendor Affiliate with the American Med Spa Association
    • FDA Approves First New Sunscreen Ingredient in 20 Years
    • Allergan Aesthetics Releases ‘The Aesthetics Evolution: What Consumers Really Want’ Highlighting Consumer Motivations and Expectations in Aesthetics